In Model 3, some adjusted variables were related to the comorbidities of obesity, abnormal liver function, hyperlipidaemia, and DM, such as body mass index, total bilirubin, direct bilirubin, TC, triglyceride, fast blood glucose, metformin, and SGLT2 inhibitor. The gene discussed is SLC5A2; the disease is hyperlipidemia.